Wikisage, the free encyclopedia of the second generation, is digital heritage

Difference between revisions of "Stiripentol"

From Wikisage
Jump to navigation Jump to search
(Sindrome de Dravet: title)
m (Notes)
 
(11 intermediate revisions by the same user not shown)
Line 1: Line 1:
Stipiripentol is adjuvant of clobazam and valproic acid<ref>[http://download.springer.com/static/pdf/288/art%253A10.1016%252Fj.nurt.2006.10.001.pdf?originUrl=http%3A%2F%2Flink.springer.com%2Farticle%2F10.1016%2Fj.nurt.2006.10.001&token2=exp=1467312883~acl=%2Fstatic%2Fpdf%2F288%2Fart%25253A10.1016%25252Fj.nurt.2006.10.001.pdf%3ForiginUrl%3Dhttp%253A%252F%252Flink.springer.com%252Farticle%252F10.1016%252Fj.nurt.2006.10.001*~hmac=688da8e86c72fbfc347f63385e69d74b33cf4459491d99140ad20407f605899f Chiron Catherine 2007 Neurotherapeutics 123-125]</ref><ref>[http://www.if-pan.krakow.pl/pjp/pdf/2005/2_154.pdf Pharmacological Reports]</ref>
+
Stipiripentol is adjuvant of [[clobazam]] and [[valproate|valproic acid]]<ref>[http://download.springer.com/static/pdf/288/art%253A10.1016%252Fj.nurt.2006.10.001.pdf?originUrl=http%3A%2F%2Flink.springer.com%2Farticle%2F10.1016%2Fj.nurt.2006.10.001&token2=exp=1467312883~acl=%2Fstatic%2Fpdf%2F288%2Fart%25253A10.1016%25252Fj.nurt.2006.10.001.pdf%3ForiginUrl%3Dhttp%253A%252F%252Flink.springer.com%252Farticle%252F10.1016%252Fj.nurt.2006.10.001*~hmac=688da8e86c72fbfc347f63385e69d74b33cf4459491d99140ad20407f605899f Chiron Catherine 2007 Neurotherapeutics 123-125]</ref><ref>[http://www.if-pan.krakow.pl/pjp/pdf/2005/2_154.pdf Pharmacological Reports]</ref>
 
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157067/ Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy]</ref>
 
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157067/ Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy]</ref>
 
==Use==
 
==Use==
 
<ref>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652007/pdf/nihms266887.pdf</ref>
 
<ref>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652007/pdf/nihms266887.pdf</ref>
==Sindrome de Dravet==
+
==[[Dravet%27s_syndrome|Dravet's Syndrome]]==
 
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913306/pdf/i1535-7511-14-1-22.pdf Stiripentol for Dravet Syndrome: Is It Worth It?]<ref>https://static-content.springer.com/lookinside/art%3A10.1007%2Fs40263-012-0004-3/000.png</ref>
 
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913306/pdf/i1535-7511-14-1-22.pdf Stiripentol for Dravet Syndrome: Is It Worth It?]<ref>https://static-content.springer.com/lookinside/art%3A10.1007%2Fs40263-012-0004-3/000.png</ref>
<ref>[http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/epdf Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders]</ref><ref>[http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2006.00497.x/pdf Stiripentol, a Putative Antiepileptic Drug, Enhances the Duration
+
<ref>[http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/epdf Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders]</ref><ref>[http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2006.00497.x/pdf Stiripentol, a Putative Antiepileptic Drug, Enhances the Duration of Opening of GABAA-Receptor Channels]</ref><ref>http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/000664/WC500036518.pdf</ref><ref>http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2011.03008.x/epdf</ref>
of Opening of GABAA-Receptor Channels]</ref><ref>http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/000664/WC500036518.pdf</ref><ref>http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2011.03008.x/epdf</ref>
 
  
 
<gallery>
 
<gallery>
Line 12: Line 11:
 
</gallery>
 
</gallery>
  
Dravet
+
[[Dravet's syndrome|Dravet]]
  
 
<ref>[http://www.epilepsybehavior.com/article/S1525-5050(14)00698-2/pdf The European patient with Dravet syndrome: Results from abparent-reported survey on antiepileptic drug use in the European population with Dravet syndrome]</ref>
 
<ref>[http://www.epilepsybehavior.com/article/S1525-5050(14)00698-2/pdf The European patient with Dravet syndrome: Results from abparent-reported survey on antiepileptic drug use in the European population with Dravet syndrome]</ref>
Line 19: Line 18:
  
 
[http://flexikon.doccheck.com/de/Stiripentol FLexikon:Stiripentol]
 
[http://flexikon.doccheck.com/de/Stiripentol FLexikon:Stiripentol]
 +
 +
 +
{{Wikidata|Q412182}}
  
 
==Notes==
 
==Notes==
<references/>
+
{{refs}}
 +
[[Category:anticonvulsants]]

Latest revision as of 00:20, 27 February 2019